Drug Trial Radar · NCT04315467
Intraoperative Imaging of Pulmonary Nodules by SGM-101
Last checked: Nov 19, 2026Latest source record: Jun 16, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Jul 8, 2020
Primary completion
Feb 10, 2022
Study completion Feb 10, 2022
Sponsor
- Lead sponsor
- Sunil SinghalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 19, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objectives of this study are to assess the sensitivity and specificity of SGM-101 in detecting non-small cell lung carcinomas during surgery when excited by an near-infrared light source utilizing intraoperative imaging.
Conditions
- Lung Cancer
- Lung Nodule
- Non Small Cell Lung Cancer
Interventions
SGM-101Drug
A one-time infusion of SGM-101
Near infrared camera imaging systemDevice
Near infrared camera imaging system
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sensitivity measure of SGM-101 uptake and expression in identifying non-small cell lung cancerTime frame: Up to 10 days post surgery (completion of pathology report)
- Specificity measure of SGM-101 uptake and expression in identifying non-small cell lung cancerTime frame: Up to 10 days post surgery (completion of pathology report)
- Number of Adverse Events (AEs) and Treatment-emergent Adverse Events (TEAEs)Time frame: Up to 4 weeks post surgery (completion of post-operative follow-up visit)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.